Sep 25, 2012 | Recent Deals | Los Angeles
Paul Hastings LLP, a leading global law firm, announced today that the firm represented the shareholders of Paragon Biomedical, Inc., a full-service clinical research organization, in the successful sale of their shares to Clinipace, Inc., a digital contract research organization for emerging and mid-tier biopharmaceutical and medical device firms.
The terms of the transaction were not disclosed.
Paul Hastings M&A partner Rob Carlson led the Paul Hastings team, which also included Tax partner Douglas Schaaf and M&A associates Lisa Tran and Nasym Korloo.
Related Posts:
- Paul Hastings Advises EIG Global Energy Partners in Settlement of Lawsuit Challenging Acquisition of the TCW Group by Carlyle Group
- Paul Hastings Represents Castle & Cooke Cold Storage in Sale to Lineage Logistics and Investor Bay Grove Capital
- Paul Hastings Representing Fitness International In Acquisition of 171 Bally Total Fitness Clubs
- Paul Hastings Represents Wells Fargo in Financing for Golden Gate Capital’s Acquisition of Ex-Libris Group
- Paul Hastings Represents Miro Holdings in Sale to the Boeing Company
